SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celltech Group (NYSE: CLL)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (48)10/17/2002 5:04:48 AM
From: nigel bates   of 123
 
LONDON, Oct 17 (Reuters) - Celltech Group Plc , Britain's biggest biotech firm, said on Thursday its arthritis drug CDP 870 was also showing promise in treating Crohn's disease, a serious bowel disorder.
Phase II trial data, presented at an analyst R&D day, showed CDP 870 achieved "highly clinically and statistically significant responses and remission rates" in patients with active inflammation...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News